Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1988 Apr;32(4):568–572. doi: 10.1128/aac.32.4.568

Disposition of amopyroquin in rats and rabbits and in vitro activity against Plasmodium falciparum.

E Pussard 1, F Verdier 1, F Faurisson 1, F Clavier 1, F Simon 1, C Gaudebout 1
PMCID: PMC172222  PMID: 3288115

Abstract

The disposition of amopyroquin was studied in rats after a single 50-mg/kg (body weight) oral dose of amopyroquin base. After a rapid absorption phase, the drug concentrations decreased in the plasma, with a terminal half-life of 14.5 h. The drug was widely distributed in the liver and lungs and, to a lesser extent, in the kidneys and spleen. In rabbits, the kinetic parameters were compared after a single 10-mg/kg dose of amopyroquin base through intravenous, intramuscular (i.m.), and oral routes. The similar bioavailability values (0.67 and 0.69) suggested that the drug could be used through i.m. or oral administration. Clearance and distribution volume did not differ significantly among the three modes of administration, and the terminal half-lives were 18.1 +/- 3.3, 23.9 +/- 6.7, and 25.7 +/- 5.4 h for intravenous, i.m., and oral routes, respectively. The ratio of concentrations in erythrocytes and plasma was about 5 in rats and rabbits. Three metabolites were detected in both animal species (one was tentatively identified as the primary amine derivative). The amopyroquin in vitro activity was tested against four chloroquine-susceptible and 11 chloroquine-resistant African Plasmodium falciparum strains. For all isolates, the 50% inhibitory concentrations of amopyroquin were much lower than those of chloroquine and monodesethylamodiaquine.

Full text

PDF
568

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelusi S. A., Salako L. A. Tissue and blood concentrations of chloroquine following chronic administration in the rat. J Pharm Pharmacol. 1982 Nov;34(11):733–735. doi: 10.1111/j.2042-7158.1982.tb06211.x. [DOI] [PubMed] [Google Scholar]
  2. Churchill F. C., Patchen L. C., Campbell C. C., Schwartz I. K., Nguyen-Dinh P., Dickinson C. M. Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. Life Sci. 1985 Jan 7;36(1):53–62. doi: 10.1016/0024-3205(85)90285-1. [DOI] [PubMed] [Google Scholar]
  3. Coleman M. D., Edwards G., Braithwaite I. M., Breckenridge A. M. High-performance liquid chromatographic method for the determination of amopyroquine in biological fluids. J Chromatogr. 1987 Feb 20;414(1):242–247. doi: 10.1016/0378-4347(87)80048-8. [DOI] [PubMed] [Google Scholar]
  4. Frisk-Holmberg M., Bergqvist Y., Termond E., Domeij-Nyberg B. The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects. Eur J Clin Pharmacol. 1984;26(4):521–530. doi: 10.1007/BF00542151. [DOI] [PubMed] [Google Scholar]
  5. HOEKENGA M. T. Intramuscular amopyroquin for acute malaria. Am J Trop Med Hyg. 1962 Jan;11:1–5. doi: 10.4269/ajtmh.1962.11.1. [DOI] [PubMed] [Google Scholar]
  6. HOEKENGA M. T. Propoquin in treatment of malaria. Am J Trop Med Hyg. 1957 Nov;6(6):987–989. doi: 10.4269/ajtmh.1957.6.987. [DOI] [PubMed] [Google Scholar]
  7. Larrey D., Castot A., Pëssayre D., Merigot P., Machayekhy J. P., Feldmann G., Lenoir A., Rueff B., Benhamou J. P. Amodiaquine-induced hepatitis. A report of seven cases. Ann Intern Med. 1986 Jun;104(6):801–803. doi: 10.7326/0003-4819-104-6-801. [DOI] [PubMed] [Google Scholar]
  8. Le Bras J., Andrieu B., Hatin I., Savel J., Coulaud J. P. Plasmodium falciparum: interprétation du semi-microtest de chimiosensibilité in vitro par incorporation de 3H-hypoxanthine. Pathol Biol (Paris) 1984 May;32(5):463–466. [PubMed] [Google Scholar]
  9. Neftel K. A., Woodtly W., Schmid M., Frick P. G., Fehr J. Amodiaquine induced agranulocytosis and liver damage. Br Med J (Clin Res Ed) 1986 Mar 15;292(6522):721–723. doi: 10.1136/bmj.292.6522.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pussard E., Clavier F., Verdier F. Liquid chromatographic determination of amopyroquine in rabbit plasma and red blood cells. J Chromatogr. 1987 Oct 9;421(1):192–197. doi: 10.1016/0378-4347(87)80397-3. [DOI] [PubMed] [Google Scholar]
  11. Pussard E., Verdier F., Blayo M. C., Pocidalo J. J. Biotransformation de l'amodiaquine et prophylaxie du paludisme à Plasmodium falciparum. C R Acad Sci III. 1985;301(8):383–385. [PubMed] [Google Scholar]
  12. Pussard E., Verdier F., Faurisson F., Scherrmann J. M., Le Bras J., Blayo M. C. Disposition of monodesethylamodiaquine after a single oral dose of amodiaquine and three regimens for prophylaxis against Plasmodium falciparum malaria. Eur J Clin Pharmacol. 1987;33(4):409–414. doi: 10.1007/BF00637639. [DOI] [PubMed] [Google Scholar]
  13. Salako L. A., Adelusi S. A. Plasma, whole blood and red blood cell kinetics of chloroquine after oral and parenteral administration in rabbits. Arch Int Pharmacodyn Ther. 1983 Jan;261(1):4–15. [PubMed] [Google Scholar]
  14. Schmidt L. H., Vaughan D., Mueller D., Crosby R., Hamilton R. Activities of various 4-aminoquinolines against infections with chloroquine-resistant strains of Plasmodium falciparum. Antimicrob Agents Chemother. 1977 May;11(5):826–843. doi: 10.1128/aac.11.5.826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Verdier F., Clavier F., Deloron P., Blayo M. C. Distribution de la chloroquine et de la déséthyl-chloroquine dans le sang, le plasma et les érythrocytes de sujets sains et paludéens. Dosage en HPLC. Pathol Biol (Paris) 1984 May;32(5):359–361. [PubMed] [Google Scholar]
  16. Verdier F., Le Bras J., Clavier F., Hatin I. Blood levels and in vitro activity of desethylchloroquine against Plasmodium falciparum. Lancet. 1984 May 26;1(8387):1186–1187. doi: 10.1016/s0140-6736(84)91436-3. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES